Please try another search
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.
Name | Age | Since | Title |
---|---|---|---|
Bridget Ann Martell | 57 | 2021 | Independent Director |
Thomas Sellig | - | 2023 | Director |
Vaughn B. Himes | 62 | 2022 | Independent Director |
Thomas B. King | 68 | 2023 | Director |
Cindy Jacobs | 65 | 2008 | President, Chief Medical Officer & Director |
John A. Bencich | 46 | 2014 | CEO & Director |
Stuart Duty | 58 | 2023 | Director |
Richard A. B. Stewart | 64 | 2017 | Executive Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review